entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 22:59:49 - browse：2597

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： Quicker fix for pulse oximeters urged during FDA public meeting

WSS

Congressmen charge Covid hearing ‘could have been an email’

New report analyzes digital physical therapy solutions' effectiveness

Report captures long Covid’s disabling effects and policy challenges

Quicker fix for pulse oximeters urged during FDA public meeting

NIH tests clinical research in primary care with $30 million program

Statins may not be needed by millions of people, study suggests

Wikipedia

entertainment

leisure time

Jerome Adams on the need for new antivirals for Covid

The system is set up to fail children with medical complexity

Bright Health sells Medicare Advantage business to Molina

Medicare drug price negotiation’s day in court

George Santos makes 1st court appearance after pleading not guilty to 13 counts

5 takeaways from STAT's examination of Zynex Medical

Medicare proposal to cover medical devices draws a mixed reaction

New report analyzes digital physical therapy solutions' effectiveness

Novavax promises a turnaround & Lilly roils the obesity market

Cheap, fast test for Zika and dengue could cost just $1

explore

Woodcock on FDA’s accelerated approval and her next chapter

'Essentially witchcraft:' A former naturopath takes on the field

Some dementia cases could be undiagnosed liver disease

Medicare drug price negotiation’s day in court

Do digital therapeutics have a future in medicine?

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Wikipedia

explore

hotspot

explore